Hydroxyl radical production in the substantia nigra after 6- hydroxydopamine and hypoxia-reoxygenation

Brain Research

Volumn 813, Issue 1, 1998, Pages 18-25

  Dajas Bailador, Federico A ^a   Martinez Borges, Anibal ^a   Costa, Gustavo ^a   Abin, J Andrés ^a   Martignoni, Emilia ^b   Nappi, Giuseppe ^b   Dajas, Federico ^a  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

6 OHDA; Cytochrome P450; Hydroxyl radical; Hypoxia; Oxidative stress; Parkinson's disease; Substantia nigra

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; CYTOCHROME P450; DOPAMINE; HYDROXYL RADICAL; NEUROTOXIN; OXIDOPAMINE; OXYGEN; SALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME METABOLISM; MALE; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REOXYGENATION; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; DOPAMINE; HYDROXYBENZOIC ACIDS; HYDROXYL RADICAL; HYDROXYLATION; HYPOXIA, BRAIN; MALE; NEUROTOXINS; OXIDOPAMINE; OXYGEN; PARTIAL PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; SALICYLIC ACID; SUBSTANTIA NIGRA;

EID: 0032583243     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00989-5     Document Type: Article

References (34)

1. Altar C.A., Marien M.R., Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. J. Neurochem. 48:1987;390-399.
2. Asanuma M., Ogawa N., Nishibayashi S., Kawai M., Kondo Y., Iwata E. Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain. Arch. Int. Pharmacodyn. Ther. 329:1995;221-230.
3. Asanuma M., Hirata H., Cadet J.L. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. Neuroscience. 85:1998;907-917.
4. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberg F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20:1973;415-455.
5. Cadet J.L., Katz M., Jackson-Lewis V., Fahn S. Vitamin E attenuates the toxic effects of intrastrial injection of 6-hydroxydopamine in rats: behavioral and biochemical evidence. Brain. Res. 476:1989;10-15.
6. Chan P.H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
7. Chand P., Clausen J. Effects of phenobarbital and sodium salicylate on cytochrome P450 mixed function oxygenase and glutathione s-transferase activities in rat brain. Chem. Biol. Interact. 40:1992;357-363.
8. Chiueh C.C., Krishna G., Tulsi P., Obata T., Lang K., Huang S.J., Murphy D.L. Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+. Free Radic. Biol. Med. 13:1992;581-583.
9. Cohen G., Heikkila R.E. The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J. Biol. Chem. 249:1974;2447-2452.
10. Coleman T., Ellis S.W., Martin I.J., Lennard M.S., Tucker G.T. MPTP is N-demetylated by cytochromes P450 2D6, 1A2 and 3A4: implications for susceptibility to Parkinson's disease. J. Pharmacol. Exp. Ther. 277:1996;685-690.
11. Coudray C., Talla M., Martin S., Fatome M., Favier A. High pressure liquid chromatography and electrochemical detection of salicylate hydroxylation products as an in vivo marker of oxidative stress. Anal. Biochem. 227:1995;101-111.
12. Ebadi M., Srinivasan S.K., Baxi M.D. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48:1996;1-19.
13. Floyd R.A., Henderson R., Watson J.J., Wong P.K. Use of salicylate with high pressure liquid chromatography and electrochemical detection as a sensitive measure of hydroxyl free radicals in adriomycin treated rats. Free Radic. Biol. Med. 2:1986;13-18.
14. Floyd R.A., Watson J.J., Wong P.K. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol acid salicylate hydroxylation products. J. Biochem. Biophys. Methods. 10:1984;221-235.
15. Gerlach M., Riederer P. Animal models of Parkinson disease: an empirical comparison with the phenomenology of the disease in man. J. Neural. Transm. 103:1996;987-1041.
16. Gilham D.E., Cairns W., Paine M.J., Modi S., Poulson R., Roberts G.C., Wolf C.R. Metabolism of MPTP by cytochrome P450 2D6 and the demonstration of 2D6 mRNA in human fetal and adult brain by in situ hybridization. Xenobiotica. 27:1997;111-125.
17. Giovanni A., Liang L.P., Mastings T.G., Zigmond M.J. Estimating OH radical content in rat brain using systemic and intraventricular salicylate: impact of metamphetamine. J. Neurochem. 64:1995;1819-1825.
18. Grootveld M., Halliwell B. Aromatic hydroxilation as a potential measure of hydroxyl radical formation in vivo. Biochem. J. 237:1986;499-504.
19. 2 deprivation in the central nervous system on mechanism of neuronal response, differential sensitivity and injury. Prog. Neurobiol. 40:1992;277-318.
20. Halliwell B., Kaur H., Ingelman-Sundberg M. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic. Biol. Med. 10:1991;439-441.
21. Ingelman-Sundberg M., Kaur H., Terelius Y., Persson J.O., Halliwell B. Hydroxilation of salicylate by microsomal fractions and cytochrome P450. Biochem. J. 276:1991;753-757.
22. Jeon B.S., Jackson-Lewis V., Burke R.E. 6-hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration. 4:1995;131-137.
23. Knoll J. The pharmacology of (-) deprenyl. J. Neurol. Transm. 22:1986;75-89. (suppl).
24. Naudin B., Saligaut C., Costentin J. Influence of oxygen availability on the neurotoxic effect of 6-hydroxydopamine on nigrostriatal domapinergic neurons. Neurosci. Lett. 130:1991;22-26.
25. Norris P.J., Hardwick J.P., Emson P.C. Regional distribution of cytochrome P450 2D1 in the rat central nervous system. J. Comp. Neurol. 366:1996;244-258.
26. O'Connell M.J., Webster N.R. Hyperoxia and salicylate metabolism in rats. J. Pharm. Pharmacol. 42:1990;205-206.
27. G. Paxinos, G. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Australia, 1986.
28. Pearigen P., Gwinn R., Simon R.P. The effects in vivo of hypoxia on brain injury. Brain Res. 725:1996;184-191.
29. Perumal A.S., Gopal V.B., Tordzro K., Cooper T.B., Cadet J.L. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging system in rat brain. Brain Res. Bull. 29:1992;699-701.
30. Piantadosi C.A., Zhang J., Demchenko I.T. Production of OH in the hippocampus after CO hypoxia or hipoxic hypoxia in the rat. Free Radic. Biol. Med. 22:1997;725-732.
31. Sachs C.H., Jonsson G. Mechanism of action of 6-hydroxydopamine. Pharmacology. 24:1975;1-8.
32. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36:1996;83-106.
33. U. Ungerstedt, Histochemical studies on the effect of intracerebral and intraventricular injections of 6-hydroxydopamine on monoamine neurons in the rat brain, in: T. Malmfors, H. Thoenen (Eds.), 6-Hydroxydopamine and Cathecolamine Neurons, North-Holland, Amsterdam, 1971, pp. 101-127.
34. Wyss A., Gustafsson J.A., Warner M. Cytochromes P450 of the 2D subfamily in rat brain. Mol. Pharmacol. 47:1995;1148-1155.